Company Focus
Acasti was established in August 2008 as a subsidiary of Neptune Technologies & Bioressources Inc. Neptune has granted to Acasti an exclusive worldwide license to research and develop new active pharmaceutical ingredients based on Neptune’s proprietary marine-based omega‐3 phospholipid technology and intellectual property. Acasti is focused on bridging the treatment gap in cardiometabolic disorders through novel superior lipid management. To carry out this mission, it is advancing its portfolio of bioactive ingredients, by purifying and concentrating Neptune krill extracts through innovative technology, producing products targeting the pharmaceutical prescription medical food, OTC and prescription drug markets.
Investor & Shareholder Information
Stock Exchange ListingTSX – Venture Exchange - Symbol: APONASDAQ – Symbol: ACST Investors RelationsJohn RipplingerDirector of Investor Relations Acasti Pharma Inc. This e-mail address is being protected from spambots. You need JavaScript enabled to view it. Xavier Harland Chief Financial Officer Acasti Pharma Inc. This e-mail address is being protected from spambots. You need JavaScript enabled to view it. Financial informations are available under the Web site at: www.sedar.com Head OfficeAcasti Pharma Inc.545 Promenade du Centropolis, Suite 100 Laval, Québec H7T 0A3 Canada Phone: +1 450.686.4555 Fax: +1 450.686.2505 www.acastipharma. com This e-mail address is being protected from spambots. You need JavaScript enabled to view it. AuditorsKPMG LLPLimited liability partnership Chartered Accountants Bureau 1500 600 West, de Maisonneuve Blvd Montréal H3A 0A3 Canada |
Annual MeetingShareholders are invited to attend the Annual and Special Meeting being held on Thursday, June 21, 2012 at 10:00 a.m. local time atHilton Garden Inn Montréal Centre-ville Charles de Bleury Room 380 Sherbrooke West Montréal, Québec H3A 0B1 Those unable to do so are asked to sign and return the form of proxy that has been mailed to them. Transfer Agent And RegistrarFor registered shareholders:To change your address, transfer shares, eliminate duplicate mailings, have dividends deposited directly into accounts at financial institutions in Canada and in USA that provide electronic fund-transfer services, etc., please contact: Computershare Trust Company of Canada 1500 University Street, 7th Floor Montreal, Quebec H3A 3S8 Canada Computershare Trust Company of Canada 9th Floor, 100 University Avenue Toronto, Ontario M5J 2Y1 Canada Phone: 1-800-564-6253 / 514=982-7555 Fax: 1-888-453-0330 / 416-263-9394 This e-mail address is being protected from spambots. You need JavaScript enabled to view it. |